Tapewire

Nasdaq · USD

CALC

CalciMedica, Inc.

Export transactions ↓
Tapewire entity
7804
SEC CIK
0001534133
Parsed reports
265

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202610
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 01, 2022 Filed Dec 1, 2022 21:50 UTC
Zamiri ParisaChief Medical Officer
Tax withholdingCommon Stock 2,752 $0.63 $1,733.76
Disclosure

SEC source: 0001209191-22-059206 · doc4.xml · nonDerivative · entry 2

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,577

Read SEC document
December 01, 2022 Filed Dec 1, 2022 21:50 UTC
Zamiri ParisaChief Medical Officer
Exercise / conversionCommon Stock 9,375 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-059206 · doc4.xml · nonDerivative · entry 1

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,329

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
December 01, 2022 Filed Dec 1, 2022 21:49 UTC
Guerard FredericDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 28,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-059205 · doc4.xml · derivative · entry 3

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 281,250

Underlying: Common Stock · 28,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
December 01, 2022 Filed Dec 1, 2022 21:49 UTC
Guerard FredericDirector · Chief Executive Officer
Tax withholdingCommon Stock 11,068 $0.63 $6,972.84
Disclosure

SEC source: 0001209191-22-059205 · doc4.xml · nonDerivative · entry 2

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 157,530

Read SEC document
December 01, 2022 Filed Dec 1, 2022 21:49 UTC
Guerard FredericDirector · Chief Executive Officer
Exercise / conversionCommon Stock 28,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-059205 · doc4.xml · nonDerivative · entry 1

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 168,598

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 24, 2022 Filed Nov 29, 2022 16:38 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 28,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-058951 · doc4.xml · derivative · entry 3

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,875

Underlying: Common Stock · 28,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
November 24, 2022 Filed Nov 29, 2022 16:38 UTC
BREUIL ROBERT SChief Financial Officer
Tax withholdingCommon Stock 9,726 $0.67 $6,516.42
Disclosure

SEC source: 0001209191-22-058951 · doc4.xml · nonDerivative · entry 2

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,294

Read SEC document
November 24, 2022 Filed Nov 29, 2022 16:38 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionCommon Stock 28,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-058951 · doc4.xml · nonDerivative · entry 1

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 24, 2022 Filed Nov 29, 2022 21:36 UTC
Guerard FredericDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 65,625 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-058949 · doc4.xml · derivative · entry 3

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 984,375

Underlying: Common Stock · 65,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
November 24, 2022 Filed Nov 29, 2022 21:36 UTC
Guerard FredericDirector · Chief Executive Officer
Tax withholdingCommon Stock 25,824 $0.67 $17,302.08
Disclosure

SEC source: 0001209191-22-058949 · doc4.xml · nonDerivative · entry 2

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,473

Read SEC document
November 24, 2022 Filed Nov 29, 2022 21:36 UTC
Guerard FredericDirector · Chief Executive Officer
Exercise / conversionCommon Stock 65,625 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-058949 · doc4.xml · nonDerivative · entry 1

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,297

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 24, 2022 Filed Nov 29, 2022 21:37 UTC
Zamiri ParisaChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 28,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-058950 · doc4.xml · derivative · entry 3

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,875

Underlying: Common Stock · 28,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
November 24, 2022 Filed Nov 29, 2022 21:37 UTC
Zamiri ParisaChief Medical Officer
Tax withholdingCommon Stock 8,255 $0.67 $5,530.85
Disclosure

SEC source: 0001209191-22-058950 · doc4.xml · nonDerivative · entry 2

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,954

Read SEC document
November 24, 2022 Filed Nov 29, 2022 21:37 UTC
Zamiri ParisaChief Medical Officer
Exercise / conversionCommon Stock 28,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-058950 · doc4.xml · nonDerivative · entry 1

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,209

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
September 23, 2022 Filed Sep 26, 2022 16:17 UTC
BREUIL ROBERT SChief Financial Officer
Tax withholdingCommon Stock 1,684 $0.97 $1,626.91
Disclosure

SEC source: 0001209191-22-051242 · doc4.xml · nonDerivative · entry 2

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,895

Read SEC document
September 04, 2022 Filed Sep 26, 2022 16:17 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-051242 · doc4.xml · derivative · entry 3

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/12 of the total shares on September 4, 2022, but were not settled and issued until September 23, 2022. 1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
September 04, 2022 Filed Sep 26, 2022 16:17 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionCommon Stock 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-051242 · doc4.xml · nonDerivative · entry 1

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
August 24, 2022 Filed Aug 26, 2022 16:49 UTC
BREUIL ROBERT SChief Financial Officer
GrantRestricted Stock Units · Derivative 450,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-047724 · doc4.xml · derivative · entry 1

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs shall vest as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
August 24, 2022 Filed Aug 26, 2022 20:49 UTC
Zamiri ParisaChief Medical Officer
GrantRestricted Stock Units · Derivative 450,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-047723 · doc4.xml · derivative · entry 1

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs shall vest as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
August 24, 2022 Filed Aug 26, 2022 20:48 UTC
Guerard FredericDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 1,050,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-22-047722 · doc4.xml · derivative · entry 1

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,050,000

Underlying: Common Stock · 1,050,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs shall vest as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 17:17 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 9,937 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-047234 · doc4.xml · derivative · entry 3

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 109,313

Underlying: Common Stock · 9,937 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 17:17 UTC
BREUIL ROBERT SChief Financial Officer
Tax withholdingCommon Stock 3,347 $0.97 $3,246.59
Disclosure

SEC source: 0001209191-22-047234 · doc4.xml · nonDerivative · entry 2

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,579

Read SEC document
August 19, 2022 Filed Aug 23, 2022 17:17 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionCommon Stock 9,937 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-047234 · doc4.xml · nonDerivative · entry 1

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,926

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:16 UTC
Zamiri ParisaChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 9,375 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-047231 · doc4.xml · derivative · entry 3

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,125

Underlying: Common Stock · 9,375 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:16 UTC
Zamiri ParisaChief Medical Officer
Tax withholdingCommon Stock 2,668 $0.97 $2,587.96
Disclosure

SEC source: 0001209191-22-047231 · doc4.xml · nonDerivative · entry 2

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,084

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:16 UTC
Zamiri ParisaChief Medical Officer
Exercise / conversionCommon Stock 9,375 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-047231 · doc4.xml · nonDerivative · entry 1

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,752

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:15 UTC
Guerard FredericDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 28,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-047229 · doc4.xml · derivative · entry 3

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,375

Underlying: Common Stock · 28,125 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:15 UTC
Guerard FredericDirector · Chief Executive Officer
Tax withholdingCommon Stock 6,596 $0.97 $6,398.12
Disclosure

SEC source: 0001209191-22-047229 · doc4.xml · nonDerivative · entry 2

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,672

Read SEC document
August 19, 2022 Filed Aug 23, 2022 21:15 UTC
Guerard FredericDirector · Chief Executive Officer
Exercise / conversionCommon Stock 28,125 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-047229 · doc4.xml · nonDerivative · entry 1

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,268

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
June 09, 2022 Filed Jun 13, 2022 17:06 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-036381 · doc4.xml · derivative · entry 2

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 5,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on September 4, 2021 but did not settle until September 22, 2021. 1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
June 09, 2022 Filed Jun 13, 2022 17:06 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionCommon Stock 5,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-036381 · doc4.xml · nonDerivative · entry 1

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 17:39 UTC GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034262 · doc4.xml · derivative · entry 2

SHAFFER CHRISTY L · CIK 0001145929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer.

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 17:39 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001209191-22-034262 · doc4.xml · derivative · entry 1

SHAFFER CHRISTY L · CIK 0001145929 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-01

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 17:36 UTC
Sauer DirkDirector
GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034260 · doc4.xml · derivative · entry 2

Sauer Dirk · CIK 0001921165 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer.

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 17:36 UTC
Sauer DirkDirector
GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001209191-22-034260 · doc4.xml · derivative · entry 1

Sauer Dirk · CIK 0001921165 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-01

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 17:35 UTC GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034256 · doc4.xml · derivative · entry 2

EASTLAND JULIA MARIE · CIK 0001500189 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer.

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 17:35 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001209191-22-034256 · doc4.xml · derivative · entry 1

EASTLAND JULIA MARIE · CIK 0001500189 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-01

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 21:32 UTC GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034252 · doc4.xml · derivative · entry 2

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer.

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 21:32 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001209191-22-034252 · doc4.xml · derivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-01

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 21:31 UTC GrantRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-034247 · doc4.xml · derivative · entry 2

ACKERMANN CHRISTINA · CIK 0001681871 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's Common Stock, subject to the reporting person's continued status as a service provider to the issuer.

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 21:31 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $0.98 $0.00
Disclosure

SEC source: 0001209191-22-034247 · doc4.xml · derivative · entry 1

ACKERMANN CHRISTINA · CIK 0001681871 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2032-06-01

F1 · derivative.exercise_date: The award vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2023 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

Read SEC document
May 19, 2022 Filed May 23, 2022 16:48 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 39,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-031353 · doc4.xml · derivative · entry 3

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,250

Underlying: Common Stock · 39,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
May 19, 2022 Filed May 23, 2022 16:48 UTC
BREUIL ROBERT SChief Financial Officer
Tax withholdingCommon Stock 16,290 $0.90 $14,678.92
Disclosure

SEC source: 0001209191-22-031353 · doc4.xml · nonDerivative · entry 2

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,989

Read SEC document
May 19, 2022 Filed May 23, 2022 16:48 UTC
BREUIL ROBERT SChief Financial Officer
Exercise / conversionCommon Stock 39,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-031353 · doc4.xml · nonDerivative · entry 1

BREUIL ROBERT S · CIK 0001241009 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:47 UTC
Zamiri ParisaChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 37,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-031350 · doc4.xml · derivative · entry 3

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,500

Underlying: Common Stock · 37,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:47 UTC
Zamiri ParisaChief Medical Officer
Tax withholdingCommon Stock 13,123 $0.90 $11,825.14
Disclosure

SEC source: 0001209191-22-031350 · doc4.xml · nonDerivative · entry 2

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,377

Read SEC document
May 19, 2022 Filed May 23, 2022 20:47 UTC
Zamiri ParisaChief Medical Officer
Exercise / conversionCommon Stock 37,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-031350 · doc4.xml · nonDerivative · entry 1

Zamiri Parisa · CIK 0001824806 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:46 UTC
Guerard FredericDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 112,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-031348 · doc4.xml · derivative · entry 3

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 337,500

Underlying: Common Stock · 112,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date.

F3 · derivative.expiration_date: The RSUs do not expire; they either vest or are canceled prior to vest date.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:46 UTC
Guerard FredericDirector · Chief Executive Officer
Tax withholdingCommon Stock 33,357 $0.90 $30,057.99
Disclosure

SEC source: 0001209191-22-031348 · doc4.xml · nonDerivative · entry 2

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,143

Read SEC document
May 19, 2022 Filed May 23, 2022 20:46 UTC
Guerard FredericDirector · Chief Executive Officer
Exercise / conversionCommon Stock 112,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-031348 · doc4.xml · nonDerivative · entry 1

Guerard Frederic · CIK 0001825009 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.